Alogliptin Pregnancy and Breastfeeding Warnings

Alogliptin is also known as: Nesina

Alogliptin Pregnancy Warnings

FDA pregnancy category: B Use alogliptin only if clearly needed and benefit outweighs potential risk.

Alogliptin was not teratogenic when administered to animals during organogenesis at doses up to 149 and 180 times the clinical dose. In addition, no harm to the developing embryo or adverse effects on the growth and development of offspring was observed when alogliptin was given to animals at approximately 95 times the clinical exposure. Following oral administration to pregnant animals, placental transfer of alogliptin was observed. Animal fertility studies showed that alogliptin had no adverse effects on embryonic development, mating, or fertility at doses approximately 172 times the clinical dose. There are no controlled data in human pregnancy. FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

Alogliptin Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web1)